AI Article Synopsis
Article Abstract
Introduction: Lung protective ventilation (LPV) has been shown to improve survival and the duration of mechanical ventilation in acute lung injury (ALI) patients. Mortality of ALI may vary by gender, which could result from treatment variability. Whether gender is associated with the use of LPV is not known.
Methods: A total of 421 severe sepsis-related ALI subjects in the Consortium to Evaluate Lung Edema Genetics from seven teaching hospitals between 2002 and 2008 were included in our study. We evaluated patients' tidal volume, plateau pressure and arterial pH to determine whether patients received LPV during the first two days after developing ALI. The odds ratio of receiving LPV was estimated by a logistic regression model with robust and cluster options.
Results: Women had similar characteristics as men with the exception of lower height and higher illness severity, as measured by Acute Physiology and Chronic Health Evaluation (APACHE) II score. 225 (53%) of the subjects received LPV during the first two days after ALI onset; women received LPV less frequently than men (46% versus 59%, P < 0.001). However, after adjustment for height and severity of illness (APACHE II), there was no difference in exposure to LPV between men and women (P = 0.262).
Conclusions: Short people are less likely to receive LPV, which seems to explain the tendency of clinicians to adhere to LPV less strictly in women. Strategies to standardize application of LPV, independent of differences in height and severity of illness, are necessary.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388675 | PMC |
| http://dx.doi.org/10.1186/cc10524 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A comparison of the effects of lung protective ventilation and conventional ventilation on the occurrence of atelectasis during laparoscopic surgery in young infants: a randomized controlled trial.
Front Med (Lausanne)
October 2024
Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Article Synopsis
- This study examined the impact of lung protective ventilation (LPV) versus conventional ventilation on reducing pulmonary atelectasis and enhancing oxygen levels in infants undergoing laparoscopic surgery.
- Eighty infants aged 1-6 months were divided into two groups, with LPV using lower tidal volumes and specific strategies for lung recruitment, while the control group used higher tidal volumes and no positive end-expiratory pressure (PEEP).
- Results indicated that LPV significantly lowered the incidence of atelectasis and improved oxygenation during surgery, but these improvements were not sustained by the time the infants were discharged from post-anesthesia care.
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation.
BMJ Open Respir Res
October 2024
Pharmacy and Health Systems Sciences, Northeastern University - Boston Campus, Boston, Massachusetts, USA.
Article Synopsis
- There may be a connection between driving pressure (∆P) during invasive mechanical ventilation (IMV) and patient outcomes, particularly in those with acute respiratory distress syndrome (ARDS) related to COVID-19 (C-ARDS).
- This study aimed to see if maintaining a daily ∆P of less than 15 cm HO, in conjunction with low tidal volume ventilation (LTVV), improves 28-day mortality compared to using LTVV alone.
- Results showed that while 28-day survival rates varied among the groups, limiting ∆P did not appear to provide significant additional survival benefits compared to LTVV alone, suggesting a need for further research in this area.
Management of severe acute respiratory distress syndrome in Australia and New Zealand (SAGE-ANZ): An observational study.
Crit Care Resusc
September 2024
Intensive Care Unit, St George Hospital, Sydney, Australia.
Article Synopsis
- The study investigates acute respiratory distress syndrome (ARDS) in ICU patients from Australia and New Zealand, focusing on patient characteristics and management practices during a multi-center analysis.
- Among the 200 participants, the average age was 55.5 years; notable findings included a low adherence to lung protective ventilation (only 10.5% on day one) and significant use of adjunctive therapies like systemic steroids.
- The in-hospital mortality rate by day 28 was 30.5%, highlighting the need for improved implementation of established treatment protocols in ARDS care.
Lung-protective ventilation and postoperative pulmonary complications during pulmonary resection in children: A prospective, single-centre, randomised controlled trial.
Eur J Anaesthesiol
December 2024
From the Department of Anesthesiology, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (CZ, SZ, RW), Department of Anesthesiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China (CZ, MZ), Cardiothoracic Surgery Department, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (RZ).
Background: Children are more susceptible to postoperative pulmonary complications (PPCs) due to their smaller functional residual capacity and higher closing volume; however, lung-protective ventilation (LPV) in children requiring one-lung ventilation (OLV) has been relatively underexplored.
Objectives: To evaluate the effects of LPV and driving pressure-guided ventilation on PPCs in children with OLV.
Design: Randomised, controlled, double-blind study.
Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments.
Antiviral Res
October 2024
Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, 94305, USA. Electronic address:
Background: In vitro passage experiments are crucial to the development of antiretroviral (ARV) drugs.
Methods: We created an online database containing data from 102 published studies in which HIV-1 or HIV-2 was cultured with increasing concentrations of the FDA-approved nucleoside RT inhibitors (NRTIs), nonnucleoside RT inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs), protease inhibitors (PIs), capsid inhibitor (CAI) lenacapavir, and nucleoside RT translocation inhibitor (NRTTI) islatravir. We summarized the mutations selected in the subset of passage experiments with NRTIs lamivudine (3TC), emtricitabine (FTC), abacavir (ABC), tenofovir (TFV), and zidovudine (AZT), NNRTIs doravirine (DOR), efavirenz (EFV), and rilpivirine (RPV), INSTIs bictegravir (BIC), cabotegravir (CAB), and dolutegravir (DTG), and PIs atazanavir (ATV), darunavir (DRV), and lopinavir (LPV).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!